| 注册
首页|期刊导航|中国药业|艾迪注射液治疗晚期肝癌35例

艾迪注射液治疗晚期肝癌35例

施宁姚 王志炎

中国药业2011,Vol.20Issue(22):96-97,2.
中国药业2011,Vol.20Issue(22):96-97,2.

艾迪注射液治疗晚期肝癌35例

Effects of Aidi Injection for Treating Advanced Liver Cancer in 35 Cases

施宁姚 1王志炎1

作者信息

  • 1. 浙江省宁波市鄞州第二医院普外科,浙江,宁波,315000
  • 折叠

摘要

Abstract

Objective To explore the clinical applications value and side effects of Aidi Injection in the treatment of advanced liver cancer. Methods 70 patients with advanced liver cancer were randomly divided into two groups. The control group(35 cases) was treated with epirubicin, cisplatin and other drugs, and the treatment group (35 cases) was added Aidi Injection based on the control group. Results Compared with control group, the immunity function in the patients treated with Aidi Injection was significantly enhanced, the clinical efficacy and quality of life were significantly increased with less adverse reaction. Conclusion Aidi Iinjection has better effect for treating advanced liver cancer and could be popularized in clinic.

关键词

艾迪注射液/晚期肝癌/治疗

Key words

Aidi injection/ Advanced liver cancer/ therapy

分类

医药卫生

引用本文复制引用

施宁姚,王志炎..艾迪注射液治疗晚期肝癌35例[J].中国药业,2011,20(22):96-97,2.

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文